Strides Pharma in advanced talks for manufacturing Covid-19 vaccine
Fri, Feb 5, 2021 1:52 PM

Strides Pharma in advanced talks for manufacturing Covid-19 vaccine

A Flip by Flipitnews
Get it on Google Play
Strides Pharma Science is in advanced talks with a “successful” Covid-19 vaccine developer to manufacture the latter’s vaccine. However, the drugmaker declined to name the vaccine developer, citing a confidentiality agreement. Once a deal is inked, the Covid-19 vaccine, developed by a global vaccine maker, will be manufactured by Strides’ biotech subsidiary Stelis Biopharma.

More great flips

Multibagger IPO: NSE SME stock doubles allottees' money in six months

Multibagger IPO: NSE SME stock doubles allottees' money in six months

Multibagger IPO: Investing in stocks is like investing in business and one should hold one's shareholding as long as one can after getting invested. A stock investor has to believe that money is not in the buying and selling of stocks but in the holding. So, one should hold the stock as long as one can and this rule implies on the primary market investors as well.

Open Flip
Mumbai: Government agencies owe BMC property tax of over Rs 3,000 crore

Mumbai: Government agencies owe BMC property tax of over Rs 3,000 crore

The BMC, which struggled to meet its property tax target this year with bills being issued as late as Feb 2024, is owed over 3,000 crore in property tax by at least seven government agencies, revealed a report on government’s outstanding property dues accessed by TOI. The MMRDA (Mumbai Metropolitan Region Development Authority) tops the list with outstanding dues.

Open Flip
Nestle India shares drop 2% after Q4 results. Buy, sell or hold?

Nestle India shares drop 2% after Q4 results. Buy, sell or hold?

Nestle India’s share price fell on Friday to the day’s low of Rs 2,511.60, dropping 2% after the company declared its Q4 results on Thursday. The standalone net profit rose 27% year-on-year (YoY) to Rs 934 crore for the March quarter as compared to Rs 737 crore a year ago.Revenue rose 9% to Rs 5,268 crore, up from Rs 4,831 crore, the FMCG major said in a regulatory filing.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon